Stocktoria

Zivo Bioscience, Inc. ZIVO

OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2000-10-06

Zivo Bioscience, Inc. statistics & valuation

P / S97.4×
Net margin-8513.4%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-45528.60% -28127.20% -8513.40% 2015201620172018201920202021202220232024
Gross margin (%)
42.00% 31.10% 2015201620172018201920202021202220232024
Operating margin (%)
-42778.40% -26267.70% -8498.90% 2015201620172018201920202021202220232024
Return on equity (%)
-144.90% 2015201620172018201920202021202220232024
Shares outstanding
132.2M 136.7M 141.1M 180.0M 413.0M 5.2M 9.4M 1.6M 2.4M 3.6M 2015201620172018201920202021202220232024
Net debt ($)
2015201620172018201920202021202220232024
Share buybacks ($)
2015201620172018201920202021202220232024
Return on assets (%)
-7965.20% -821.90% -3021.10% -3556.50% -3116.00% -4135.60% -97.40% -411.90% -1399.50% -814.60% 2015201620172018201920202021202220232024
Free cash flow margin (%)
2015201620172018201920202021202220232024
Debt / equity (×)
2015201620172018201920202021202220232024
EPS ($)
-$4.60 -$4.23 2015201620172018201920202021202220232024

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Gross margin31.1%42.0%————————
Operating margin-8498.9%-26267.7%——-42778.4%—————
Net margin-8513.4%-28127.2%——-45528.6%—————
Return on assets-814.6%-1399.5%-411.9%-97.4%-4135.6%-3116.0%-3556.5%-3021.1%-821.9%-7965.2%
Return on equity2599.5%352.6%82331.9%-144.9%80.5%138.0%65.7%61.6%44.5%61.0%
Current ratio0.800.150.943.040.010.040.020.070.050.01

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.